Epigral (NSE:EPIGRAL) COGS-to-Revenue : 0.51 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Epigral COGS-to-Revenue?

Epigral's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹2,668 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹5,246 Mil.

Epigral's COGS to Revenue for the three months ended in Mar. 2024 was 0.51.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Epigral's Gross Margin % for the three months ended in Mar. 2024 was 49.15%.

Epigral COGS-to-Revenue Historical Data

The historical data trend for Epigral's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigral COGS-to-Revenue Chart

Epigral Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.48

0.50

0.49

0.51

0.55

Epigral Quarterly Data
	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial											0.55	0.60	0.57	0.53	0.51

Epigral COGS-to-Revenue Calculation

Epigral's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	10608.149	/	19291.916
	=	0.55

Epigral's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2667.916	/	5246.33
	=	0.51

Epigral (NSE:EPIGRAL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Epigral's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	2667.916 / 5246.33
	=	49.15 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Epigral COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Epigral's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigral (NSE:EPIGRAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Epigral Ltd (NSE:EPIGRAL) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

543332:India

Address

Corporate Road, 5th Floor, 6th Floor & 7th Floor, Meghmani House, Behind Safal Profitaire, Prahladnagar, Ahmedabad, GJ, IND, 380015

Website

https://www.meghmanifinechem.com

Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.

Epigral (NSE:EPIGRAL) Headlines

No Headlines